The forecasted data for Trachea, Bronchus, or Lung Malignant Neoplasms mortality in the U.S. indicates a consistent decreasing trend from 2024 to 2028, starting at 36.3 deaths per 100,000 persons in 2024 and declining to 31.8 by 2028. In comparison to 2023, where the mortality stood at 37.5 (hypothetical data for explanation purposes), the year-on-year decline is approximately 3.3% annually, with a cumulative average growth rate (CAGR) of about -3.1% over the five-year period.
Future trends to watch include the impact of advancements in medical technology, early detection, and public health initiatives focused on reducing smoking rates and exposure to pollutants, which could further accelerate the decline in mortality rates from lung-related cancers. Ongoing research into personalized medicine and immunotherapy could also play crucial roles in shaping future mortality trends.
